iiinova — where your digital self keeps evolving

Reposted by Foundation Fighting Blindness

retina_int @retinaint.bsky.social · 02/09/2026

Foundation Fighting Blindness is hosting a virtual session, bringing together experts to discuss the latest developments in TED care. 17 October | 12–1:30 PM ET | Online Register to attend - ow.ly/Nmlf50ZIfur #ThyroidEyeDisease #EyeHealth #Ophthalmology #RareDisease

[ID: Graphic for the FFB Quarterly Vision Webinar on Thyroid Eye Disease (TED), including the webinar date, time, and branding.]

001

Reposted by Foundation Fighting Blindness

@arvoinfo.bsky.social‬ @arvoinfo.bsky.social · 05/02/2025

This month in @arvoinfo.bsky.social IOVS journal, review the largest assessment across multiple continents of genetic causality in the patient population of #InheritedRetinalDiseases: bit.ly/42Jej2V @fightblindness.bsky.social #ARVOjournals #OpenAccess

Promotional image for the February 2025 issue of ARVO's Investigative Ophthalmology & Visual Science (IOVS) journal, featuring a colorful microscopic image of cells on the cover. The text highlights the availability of new content and includes the journal's website url: iovs.arvojournals.org.

012

Reposted by Foundation Fighting Blindness

retina_int @retinaint.bsky.social · 07/02/2025

The RI Education Hub continued today with two excellent presentations on Patient Registries from Russell Wheeler and Todd Durham @fightblindness.bsky.social. Thanks to our speakers and participants for their participation and engagement #IRD #Genetics #GeneticTesting #Registries #ClinicalTrials

The image is a screenshot of a zoom session with a powerpoint slide on the left and participants on the right hand side.

022

Foundation Fighting Blindness @fightblindness.bsky.social · 06/02/2025

Age-related macular degeneration (AMD) affects millions, causing central vision loss. This simulation offers a glimpse into what those living with AMD may experience.

020

Foundation Fighting Blindness @fightblindness.bsky.social · 29/01/2025

Meet Eva. Eva Watson’s life was marked by her dedication to advancing research for blinding diseases. Her story highlights the profound impact of her contributions to driving treatments and cures for blinding diseases. Read Eva's full Beacon Story on our website at: bit.ly/4gawEZW

bit.ly

Eva Lou Schroeder Watson's Enduring Legacy

Eva Watson's life was marked by her dedication to advancing medical research for blinding diseases, and her generous bequest to the Foundation Fighting Blindness ensures her advocacy will endure. Her ...

000

Foundation Fighting Blindness @fightblindness.bsky.social · 22/01/2025

Nacuity Pharmaceuticals granted U.S. FDA fast track designation for NPI-001 (N-acetylcysteine amide) tablets for the treatment of retinitis pigmentosa. Read more on our website at: bit.ly/3E3pfhv

bit.ly

Nacuity Pharmaceuticals Granted U.S. FDA Fast Track Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa

000

Foundation Fighting Blindness @fightblindness.bsky.social · 17/01/2025

Mark your calendars! The Retinal Therapeutics Innovation Summit 2025 is happening on May 2 in Salt Lake City, UT! Hear from top experts, discuss emerging therapies, and strategize solutions to accelerate clinical applications. Seating is limited to 500—reserve now! bit.ly/4hhIOBa

bit.ly

Retinal Therapeutics Innovation Summit 2025

065

Foundation Fighting Blindness @fightblindness.bsky.social · 16/01/2025

Spring into action, VisionWalkers! Register your team for your local Spring #VisionWalk by February 1st and you’ll be entered to win an unforgettable prize: lunch with our CEO, Jason Menzo! Sign up today at www.VisionWalk.org!

visionwalk.org

VisionWalk

VisionWalk Home Page

010

Foundation Fighting Blindness @fightblindness.bsky.social · 15/01/2025

Today, we're happy to share the incredible journey of blind hockey players in New Jersey, as highlighted in the NJ Herald. This inspiring article features athletes breaking barriers and redefining what’s possible on the rink. Read the full article at: bit.ly/3DYu63K

njherald.com

'Finding your community': NJ blind hockey team looking for more players

Josh Schneider lost 98% of his eyesight and retired from teaching at age 37. Then he found blind hockey with Jersey Blind.

001